Samsara Therapeutics

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

NRG Therapeutics

This neuroscience company develops small molecule medicines targeting mitochondrial dysfunction to treat patients with Parkinson's and amyotrophic lateral sclerosis.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

Disarm Therapeutics

This biotechnology firm develops small-molecule SARM1 inhibitors to prevent axonal degeneration for patients with neurological conditions like multiple sclerosis and amyotrophic lateral sclerosis.

Scripta Therapeutics

The company develops therapeutics that modulate transcription factor activity to treat neurodegenerative diseases for patients with conditions such as Alzheimer's and Parkinson's.